Hepatology

Discover a study exploring how gut microbiome imbalances contribute to MASLD progression and offer new diagnostic and therapeutic possibilities.

Metabolic and genetic disorders emerged as the most frequent aetiological group, reflecting broader diagnostic capabilities compared to earlier studies.

Beyond the head-to-head comparison, the study also explored innovative strategies to simplify or shorten treatment.

The study offers important insights into the therapeutic potential of short-chain fatty acids supplementation in MASLD, especially in non-obese patients.

This 12-month study explored the impact of ethanol-extracted curcumin on liver health, inflammation, and metabolic parameters in individuals with MASLD.

The biomarker identifies those at highest risk of non-adherence and helps determine how much support they receive during the intervention.

Despite the well-documented association between HBV and HCC, the exact mechanisms driving HBV-induced HCC remain largely unknown.

Biliary atresia is the most common surgical cause of cholestatic jaundice in infants and the leading reason for paediatric liver transplants